InvestorsHub Logo

dafreaks

06/11/18 1:39 PM

#70875 RE: blueyedcatch #70871

What should we call your "buddy", he should have a name dont you think?

ignatiusrielly35

06/11/18 1:43 PM

#70877 RE: blueyedcatch #70871

For the love of God, people, the financial terms of the Amgen deal have been the subject of an SEC Confidential Treatment Order since August 2016. That means that there must be a clause in the agreement with Amgen that prevents ADXS from disclosing a milestone payment. It will not show up in the next quarterly report if there is a milestone for the first dosing. The lack of a PR is completely meaningless, and tells us nothing.